Trending
Berberine lowered fasting blood sugar by 0.71 mmol/L in a meta-analysis of type 2 diabetes — a modest drop that the authors call 'adjunctive' rather than a standalone fix.
This is one of the first indexed meta-analyses to bundle berberine with probiotics and synbiotics, so the evidence is still early; the effect is real but small enough that it likely matters most as a complement to standard diabetes care, not a replacement.
A meta-analysis pooling multiple studies found that berberine, along with probiotics and synbiotics, produced a statistically significant but clinically modest reduction in fasting blood sugar (about 0.71 mmol/L) and a smaller drop in HbA1c (0.19%) in people with type 2 diabetes. The researchers frame these supplements as helpful add-ons, not primary treatments — meaning the improvements are real but unlikely to transform blood sugar control on their own.
Where this fits in the evidence
This is among the first studies we've indexed on Berberine for Improved Fasting Plasma Glucose — treat it as an early signal until more research accumulates.
The study
- Meta-Analysis
- 2026-05-29
- PloS one
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.